Holen Sie sich die Stockscreener-App
0.7083
2.65%
0.0183
Handel nachbörslich:
.71
0.0017
+0.24%
Hoth Therapeutics Inc Aktie (HOTH) Neueste Nachrichten
Hoth Therapeutics Awarded U.S. Patent for Cancer-Fighting HT-KIT Oncology Platform - PR Newswire
Hoth Therapeutics shares slide after shift toward AI semiconductor strategy (HOTH) - MSN
HOTH Should I Buy - Intellectia AI
Hoth Therapeutics (NASDAQ: HOTH) pivots to AI semiconductor infrastructure as Rocket One - Stock Titan
Hoth Therapeutics to rebrand as Rocket One, enter AI chips By Investing.com - Investing.com South Africa
Hoth Therapeutics to rebrand as Rocket One, enter AI chips - Investing.com UK
Exclusive: Hoth Therapeutics to rebrand to pursue AI chip technologies - MSN
Hoth Therapeutics stock tumbles on business pivot to AI chips By Investing.com - Investing.com South Africa
Hoth Therapeutics Inc to change name to Rocket One and restructure for AI semiconductor focus - marketscreener.com
Hoth Therapeutics Inc To Change Name To Rocket One And Restructure For Ai Semiconductor Focus - TradingView
Hoth Therapeutics stock tumbles on business pivot to AI chips - Investing.com
Hoth Therapeutics Restructures as Rocket One - Moomoo
AI Chip Energy Efficiency: Hoth Therapeutics Restructures as Rocket One Inc. to Enter the AI Semiconductor Infrastructure Market with Acquisition of Exclusive Rights to Next Generation AI Semiconductor Acceleration Technology Built on Non-Volatile Nanoma - marketscreener.com
EXCLUSIVE: Hoth Therapeutics To Rebrand To Pursue AI Chip Technologies - Yahoo Finance
Hoth Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Hoth Therapeutics (NASDAQ: HOTH) Q1 loss deepens going-concern risk despite new funding - Stock Titan
HOTH.O - Reuters
TradingKey - TradingKey
Hoth Therapeutics stock (US44133K1097): Spain greenlights Phase 2a trial for HT-001 in cancer skin t - AD HOC NEWS
Hoth Therapeutics Launches Rocket One Space Subsidiary Initiative - TipRanks
Hoth Therapeutics (NASDAQ: HOTH) creates Rocket One for space assets - Stock Titan
Hoth Therapeutics Receives Nasdaq Minimum Bid Price Deficiency Notice - The Globe and Mail
Hoth Therapeutics secures European authorization in Spain - marketscreener.com
Hoth Therapeutics Secures European Authorization In Spain - TradingView
Hoth Therapeutics secures Spain approval for phase 2a trial - Investing.com
Hoth Therapeutics secures Spain approval for phase 2a trial By Investing.com - Investing.com Australia
Hoth Therapeutics Secures European Authorization in Spain for HT-001 Phase 2a Trial as Interim Data Show Strong Efficacy in Cancer Patients - The AI Journal
Cancer patients stayed on treatment as Hoth trial eased rash - Stock Titan
Hoth Therapeutics Receives Nasdaq Delisting Notice for Non-Compliance With Minimum Bid Price Rule - Minichart
Hoth Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Hoth Therapeutics (HOTH) faces Nasdaq $1 bid-price deficiency and delisting risk - Stock Titan
Why is HOTH stock up 70% after-hours today? - MSN
Exclusive: Hoth Therapeutics targets faster drug discovery with new AI platform - MSN
HOTH Technical Analysis | Trend, Signals & Chart Patterns | HOTH THERAPEUTICS INC (NASDAQ:HOTH) - ChartMill
HOTH Hoth Therapeutics Inc. posts wider than expected Q4 2025 loss even as shares climb nearly 8 percent in today's trading.Decline Risk - Cổng thông tin điện tử tỉnh Tây Ninh
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):